Provided by Tiger Trade Technology Pte. Ltd.

KINTOR PHARMA-B

1.805
+0.1106.49%
Volume:1.44M
Turnover:2.54M
Market Cap:900.70M
PE:-3.48
High:1.805
Open:1.655
Low:1.655
Close:1.695
52wk High:4.700
52wk Low:1.605
Shares:499.00M
HK Float Shares:499.00M
Volume Ratio:1.40
T/O Rate:0.29%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.519
ROE:-83.96%
ROA:-25.20%
PB:4.23
PE(LYR):-3.48
PS:23.63

Loading ...

ABBISKO-B Presents Innovative Modeling Framework for ABSK-011 in HCC at PAGE Conference

Stock News
·
Jun 04

Nationwide Joint University Graduate Recruitment Fair Held at Tibet University of Tibetan Medicine

Deep News
·
Jun 03

Great-Sun Foods Advances Business Restructuring with a 700 Million Yuan Investment to Control Shimei Pharmaceutical, Expanding into Healthcare

Deep News
·
Jun 03

Tigermed Consulting to Invest 200 Million Yuan in Shanghai Sansheng Healthcare Private Equity Fund

Stock News
·
Jun 02

Hualan's Subsidiary Invests 205 Million Yuan for 34.17% Stake in Natural Constant, Strategically Expanding into AI Pharma

Stock News
·
Jun 01

SIMCERE PHARMA Secures Exclusive Rights to Promote Pemecitinib Gel

Stock News
·
Jun 01

Kintor Pharma reports no share capital changes in May 2026; issued shares steady at 498.66 million

Bulletin Express
·
Jun 01

Kintor Pharma's Stock Surges on Promising Clinical Data for Hair Loss Treatment

Stock News
·
Jun 01

Pharmaceutical and Biologics Sector Navigates Growth and Adjustment, Focus on Bottoming and Recovery Turning Point

Stock News
·
Jun 01

Major Breakthrough at ASCO 2026: TYK MEDICINES-B's Edotinib Achieves 95.5% Intracranial Objective Response Rate, Leading the Frontline Treatment for EGFR Lung Cancer Brain Metastases

Stock News
·
Jun 01

Preliminary Phase I Data for GENFLEET-B's GFS202A in Cancer Cachexia Selected for ASCO 2026 Poster Presentation

Stock News
·
Jun 01

Kintor Pharma-B (09939): KX-826 Presents Phase III Trial Data for Androgenetic Alopecia and Combination Study at WCHR 2026, Receives Outstanding Poster Award

Stock News
·
Jun 01

Kintor Pharma Showcases Positive Phase III Results for Topical AGA Candidate KX-826 at WCHR 2026

Bulletin Express
·
Jun 01

Two Funds Double in Value as Tech Sector Shines, While Traditional Sectors Lag

Deep News
·
May 31

Key Phase II ESAONA Study Results for TYK MEDICINES-B's (02410) TY-9591 in First-Line NSCLC Brain Metastases Presented as Late-Breaking Abstract at 2026 ASCO

Stock News
·
May 31

Kintor Pharmaceutical Says CEO Via Wholly Owned Co Increases Shareholding By 2.51 Million Shares

Reuters
·
May 28

Kintor Pharmaceutical: CEO Youzhi Tong Boosts Stake by 2.51 Million Shares Through Market Purchases and RSU Exercise

Bulletin Express
·
May 28

KINTOR PHARMA-B Chairman Increases Holdings by 1.2625 Million Shares

Stock News
·
May 28

Kintor Pharmaceutical - CEO via Wholly Owned Co Increases Shareholding by 2.51 Mln Shares

THOMSON REUTERS
·
May 28

Kintor Pharmaceutical Ltd - Increased Shareholding Consideration About HK$3.32 Mln

THOMSON REUTERS
·
May 28